Synthesis and characterization of platinum(II) and (IV) complexes containing hexamethyleneimine ligand:: crystal structure of [PtII(hexamethyleneimine)2(cyclobutanedicarboxylato)]•H2O

被引:18
作者
Ali, MS
Thurston, JH
Whitmire, KH
Khokhar, AR
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA
[2] Rice Univ, Dept Chem, Houston, TX 77005 USA
基金
美国国家科学基金会;
关键词
platinum; hexamethyleneimine; 1,1-cyclobutanedicarboxylato; synthesis; crystal structure;
D O I
10.1016/S0277-5387(02)01263-9
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A series of new platinum(II) and platinum(IV) complexes of the type [Pt-II(HMI)(2)X] (where HMI = hexamethyleneimine, X = dichloro, sulfato, 1,1-cyclobutanedicarboxylato [CBDCA], oxalato, methylmalonato, or tatronato) and [Pt-IV(HMI)(2)Y2Cl2] (where Y = hydroxo, acetato, or chloro) were synthesized and characterized by infrared (IR) spectroscopy, C-13 and Pt-195 nuclear magnetic resonance (NMR) spectroscopy and elemental analysis. Among the complexes synthesized, [Pt-II(hexamethyleneimine)(2)(1,1-cyclobutanedicarboxylato)](H2O)-H-. was examined by single-crystal X-ray diffraction. The slightly distorted square planar coordination environment of the platinum metal includes the amino group of the hexamethyleneimine (HMI) molecule and the oxygen atoms of the carboxylato ligand. The cyclobutanedicarboxylic acid (CBDCA) molecule adopts six-member chelating rings with platinum. Hydrogen bonding plays an important part in holding the crystal lattice together. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2659 / 2665
页数:7
相关论文
共 32 条
[21]   Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel [J].
Rixe, O ;
Ortuzar, W ;
Alvarez, M ;
Parker, R ;
Reed, E ;
Paull, K ;
Fojo, T .
BIOCHEMICAL PHARMACOLOGY, 1996, 52 (12) :1855-1865
[22]  
Scheeff E. D., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P158
[23]  
SCHELDRICK G, 2001, SHELXTL 6 10
[24]  
SCHMIDT W, 1993, CANCER RES, V53, P799
[25]   Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group [J].
Shamsuddin, S ;
Takahashi, I ;
Siddik, ZH ;
Khokhar, AR .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1996, 61 (04) :291-301
[26]   SYNTHESIS AND CRYSTAL-STRUCTURE OF A NEW ANTITUMOR AGENT - [PT(CIS-1,4-DIAMINOCYCLOHEXANE)(1,1-CYCLOBUTANEDICARBOXYLATE)] [J].
SHAMSUDDIN, S ;
KHOKHAR, AR .
JOURNAL OF COORDINATION CHEMISTRY, 1994, 33 (01) :83-91
[27]   Synthesis and characterization of a series of lipophilic cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine ligand [J].
Shamsuddin, S ;
Ali, MS ;
Khokhar, AR .
JOURNAL OF COORDINATION CHEMISTRY, 2000, 49 (04) :291-299
[28]   Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance [J].
Siddik, ZH ;
Hagopian, GS ;
Thai, G ;
Tomisaki, S ;
Toyomasu, T ;
Khokhar, AR .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1999, 77 (1-2) :65-70
[29]  
Spek A.L., 2002, PLATON. A multipurpose crystallographic tool
[30]   Crystal structure of the anticancer drug cisplatin bound to duplex DNA [J].
Takahara, PM ;
Frederick, CA ;
Lippard, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (49) :12309-12321